IP Library Granted Patent US 7,192,608
Granted Patent B2
US 7,192,608 · App. 10/091,559 · Granted Mar 20, 2007

Method of manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,192,608
App. No.
10/091,559
Granted
Mar 20, 2007
Kind
B2
Abstract

The present invention provides coated granules using drug granules containing a water soluble drug as an active ingredient at a high density, which is superior in uniform content and stability, and which is capable of providing a pharmaceutical preparation superior in drug release control and having a smaller size than conventional preparations, and a production method of the granules, and further, a pharmaceutical preparation using the drug granules.

Claims (5)

1. A method of manufacturing a drug granule, comprising a granulation step of spraying only a solution of a water soluble drug on a crystal of said water soluble drug substantially without using a binder or in the absence of binder in a rotary fluidized bed granulate coating apparatus, wherein the drug granule has a granular strength of 650–2500 gf/mm 2 , and wherein the drug is selected from the group consisting of metformin hydrochloride, ethydronic acid di-sodium, cimetidine, carbocistein, gabapentin, ciprofloxacin hydrochloride, mexiletine hydrochloride and vancomycin hydrochloride.

2. A method of manufacturing a coated granule, which comprises:

(a) spraying a solution of a water soluble drug on a crystal of said water soluble drug obtained by a method comprising a granulation step of spraying only a solution of a water soluble drug on a crystal of said water soluble drug substantially without using a binder or in the absence of binder in a rotary fluidized bed granulate coating apparatus to form a drug granule,

wherein the drug granule has a granular strength of 650–2500 gf/mm 2 and the drug is selected from the group consisting of metformin hydrochloride, ethydronic acid di-sodium, cimetidine, carbocistein, gabapentin, ciprofloxacin hydrochloride, mexiletine hydrochloride and vancomycin hydrochloride; and

(b) coating said drug granule with a release control film coating agent.

Assignments (2)
MERGER Recorded Dec 16, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017089/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2002
From: OCHIAI, YASUSHI; WAKISAKA, KOUJI
To: SUMITOMO PHARMACEUTICALS COMPANY LIMITED
Reel/Frame 012951/0954 →